Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Research Scientist

Biochemistry · China · 2023-02-09

Processing Time
30 days
Decision Date
2023-02-09
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research on advancing novel protein characterization approaches for discovering and engineering antibodies. This work focuses on developing a protein engineering strategy to produce antibodies with improved dose potency and creating new therapeutics that target difficult diseases.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses global problems related to drug ineffectiveness and has broad implications for U.S. healthcare, specifically regarding acute liver injury treatments.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned based on her academic background, 7 publications, 82 citations, and history of performing peer reviews.

3 Waiver of Job Offer and Labor Certification Met

On balance, it was found beneficial to the U.S. to waive the requirements due to the critical nature of her antibody discovery research and NIH-supported work.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in oral biology, 7 peer-reviewed journal articles (4 first-authored), and 82 citations. Evidence included 4 expert recommendation letters, 3 peer-review assignments, and proof of funding from the National Institutes of Health (NIH) and major Chinese national science foundations.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Maryland 292 days 2025-02-27
The petitioner proposes to develop engineering approaches for the production of therapeutic antibodies and novel antibody-like proteins. Her work focuses on improving clinical outcomes in oncology, immunology, and anti-infection applications by creating tools to overcome therapeutic resistance and metastasis. Additionally, she aims to enhance production efficiency to ensure broader accessibility of life-saving treatments.
View Case

Scientist

Biotechnology · Sri Lanka

WeGreened EB-2 (NIW) approved
Ohio 3 days 2024-02-08
The petitioner proposes to continue research on developing new methodologies for engineering and characterizing novel proteins and antibodies. This work aims to further biomedical studies, the biotechnology industry, and healthcare by providing foundations for innovations in therapeutic treatments.
View Case

Postdoctoral Researcher

Biotechnology · Poland

WeGreened EB-2 (NIW) approved
California 489 days 2025-04-22
The petitioner proposes to develop synthetic antibodies with enhanced functional activity against infectious agents, specifically focusing on antibody engineering strategies for conditions like HIV. This work aims to create potent, long-acting solutions for disease prevention and treatment to lower transmission rates and healthcare burdens.
View Case

Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
Washington 369 days 2025-02-05
The petitioner proposes to advance computational algorithms and experimental screening techniques to streamline the creation of modular, low-cost, and efficient protein therapeutics. This work focuses on improving the stability and production of drugs like antibodies and insulins to eliminate cold-chain transportation barriers and reduce healthcare costs.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-02-09.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 30 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist